AGEN: Agenus Inc. Stocks News on November 20, 2025

AGEN

Business Wire

2 days ago

Agenus Appoints Dr. José Iglesias as Chief Medical Affairs Officer to Guide Global Medical Affairs and Early-Access Programs, Including France’s AAC

LGND: Target Up On Improved Growth Outlook

AGEN

Zacks Small Cap Research

10 days ago

LGND: Target Up On Improved Growth Outlook

AGEN

Zacks

10 days ago

Agenus (AGEN) Misses Q3 Earnings and Revenue Estimates

AGEN

Associated Press Finance

10 days ago

Agenus: Q3 Earnings Snapshot

AGEN

Business Wire

10 days ago

Agenus Reports Q3 2025 Results Showcasing Clinical and Regulatory Advances

Intellia Therapeutics, Inc. (NTLA) Reports Q3 Loss, Misses Revenue Estimates

AGEN

Zacks

14 days ago

Intellia Therapeutics, Inc. (NTLA) Reports Q3 Loss, Misses Revenue Estimates

Innoviva (INVA) Q3 Earnings and Revenues Beat Estimates

AGEN

Zacks

15 days ago

Innoviva (INVA) Q3 Earnings and Revenues Beat Estimates

AGEN

Business Wire

15 days ago

Agenus to Provide Corporate Update and Third Quarter 2025 Financial Report

Sarepta Therapeutics (SRPT) Reports Q3 Loss, Beats Revenue Estimates

AGEN

Zacks

17 days ago

Sarepta Therapeutics (SRPT) Reports Q3 Loss, Beats Revenue Estimates

AGEN

Business Wire

a month ago

Agenus Reports 39% of Patients Alive at Two-Years with BOT/BAL Across Multiple Refractory Solid Tumors at ESMO 2025

AGEN

Business Wire

a month ago

Agenus to Host October Stakeholder Briefing Showcasing BOT/BAL Global Momentum and Post-ESMO Insights

Sanofi's Experimental Transplant Rejection Drug Gets FDA Orphan Tag

AGEN

Zacks

5 months ago

Sanofi's Experimental Transplant Rejection Drug Gets FDA Orphan Tag

FDA Grants Label Expansion to AstraZeneca's Datroway in Lung Cancer

AGEN

Zacks

5 months ago

FDA Grants Label Expansion to AstraZeneca's Datroway in Lung Cancer

AGEN

Zacks

5 months ago

After Golden Cross, Agenus (AGEN)'s Technical Outlook is Bright

AGEN

MT Newswires

5 months ago

Agenus Partners With Noetik to Advance Biomarker Discovery for Lead Cancer Immunotherapy Combo

AGEN

Business Wire

5 months ago

Agenus and Noetik Enter Collaboration to Develop AI-Enabled Predictive Biomarkers for BOT/BAL Using Foundation Models of Virtual Cell Biology

AGEN

Insider Monkey

5 months ago

Agenus Inc. (AGEN) Surges After Zydus Agreement, Analysts Upbeat on Stock

SRPT Plummets on Second Patient Death After DMD Gene Therapy Infusion

AGEN

Zacks

5 months ago

SRPT Plummets on Second Patient Death After DMD Gene Therapy Infusion

AGEN

Business Wire

5 months ago

Agenus Announces Virtual Annual Shareholders Meeting

AGEN

MT Newswires

6 months ago

Agenus Shares Rise After Upgrade From HC Wainwright

AGEN

Zacks

6 months ago

Wall Street Analysts Believe Agenus (AGEN) Could Rally 26.6%: Here's is How to Trade

AGEN

Pharmaceutical Technology

6 months ago

Agenus and Zydus sign agreements for botensilimab and balstilimab

AGEN

MT Newswires

6 months ago

HC Wainwright Upgrades Agenus to Buy From Neutral, $25 Price Target

AGEN

MT Newswires

6 months ago

Agenus to Sell US Manufacturing Facilities to Zydus Lifesciences

AGEN

Business Wire

6 months ago

Agenus and Zydus Lifesciences Enter $141M Strategic Collaboration to Advance BOT/BAL, Expand Zydus’ Biologics Manufacturing in the US

AGEN

Business Wire

6 months ago

Agenus Presents New Data at ASCO Highlighting Botensilimab’s Immune Activation in MSS Colorectal Cancer

AGEN

Zacks

6 months ago

Despite Fast-paced Momentum, Agenus (AGEN) Is Still a Bargain Stock

AGEN

Business Wire

6 months ago

Agenus Announces New Data from Expanded MSS Metastatic Colorectal Cancer Cohort to be Presented at ESMO GI 2025

AGEN

GuruFocus.com

6 months ago

Agenus Inc (AGEN) Q1 2025 Earnings Call Highlights: Strategic Moves and Financial Challenges

AGEN

Thomson Reuters StreetEvents

6 months ago

Q1 2025 Agenus Inc Earnings Call

AGEN

Zacks

6 months ago

Agenus (AGEN) Reports Q1 Loss, Tops Revenue Estimates

AGEN

Associated Press Finance

6 months ago

Agenus: Q1 Earnings Snapshot

AGEN

Business Wire

6 months ago

Agenus Reports Q1 2025 Financial Results and Key Business Updates

AGEN

Business Wire

6 months ago

Renowned GI Oncology Leader Dr. Richard Goldberg Joins Agenus as Chief Development Officer

AGEN

GuruFocus.com

6 months ago

Agenus Inc (AGEN) Q1 2025: Everything You Need To Know Ahead Of Earnings

Is ANI Pharmaceuticals (ANIP) Outperforming Other Medical Stocks This Year?

AGEN

Zacks

6 months ago

Is ANI Pharmaceuticals (ANIP) Outperforming Other Medical Stocks This Year?

AGEN

Zacks

7 months ago

Agenus (AGEN) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

AGEN

Business Wire

7 months ago

Agenus to Provide Corporate Update and First Quarter 2025 Financial Report

AGEN

Business Wire

7 months ago

Agenus’ BOT/BAL Neoadjuvant Pan-Cancer Data from the NEOASIS Study Presented in an Oral Session at AACR

AGEN

Business Wire

7 months ago

Agenus’ BOT/BAL Data in Pretreated Liver Cancer Presented at AACR 2025

AGEN

Business Wire

7 months ago

Agenus Announces Botensilimab and Balstilimab Presentations at ASCO 2025

Are Medical Stocks Lagging ANI Pharmaceuticals (ANIP) This Year?

AGEN

Zacks

7 months ago

Are Medical Stocks Lagging ANI Pharmaceuticals (ANIP) This Year?

AGEN

Business Wire

8 months ago

Agenus to Present New BOT/BAL Data in Two Presentations at AACR 2025

AGEN

Zacks

8 months ago

Here's Why Agenus (AGEN) Is a Great 'Buy the Bottom' Stock Now

AGEN

Business Wire

8 months ago

Agenus Unveils Colorectal Cancer Survey Findings, Highlighting the Urgent Need for Treatment Innovation

AGEN

GuruFocus.com

8 months ago

Agenus Inc (AGEN) Q4 2024 Earnings Call Highlights: Strategic Moves Amid Financial Challenges

AGEN

Thomson Reuters StreetEvents

8 months ago

Q4 2024 Agenus Inc Earnings Call

AGEN

Motley Fool

8 months ago

Agenus (AGEN) Q4 2024 Earnings Call Transcript

AGEN

Zacks

8 months ago

Agenus (AGEN) Reports Q4 Loss, Lags Revenue Estimates

AGEN

Associated Press Finance

8 months ago

Agenus: Q4 Earnings Snapshot

AGEN

Business Wire

8 months ago

Agenus Reports Q4 and Year-End 2024 Results; Strategic Operational Improvements and Significant Cost Reductions Enhance Sustainability of Promising BOT/BAL Program

Kura Oncology (KURA) Reports Q4 Loss, Lags Revenue Estimates

AGEN

Zacks

9 months ago

Kura Oncology (KURA) Reports Q4 Loss, Lags Revenue Estimates

AGEN

Business Wire

9 months ago

Agenus Reports Impact of Key Immuno-Oncology Data Presented at Leading Medical Conferences and Peer-Reviewed Publications

AGEN

Business Wire

9 months ago

Agenus to Participate in B. Riley Securities Precision Oncology & Radiopharma Investor Conference

AGEN

Business Wire

9 months ago

Agenus to Provide Corporate Update and Fourth Quarter & Full Year 2024 Financial Report

AGEN

Business Wire

9 months ago

Agenus Presents New Botensilimab/Balstilimab Data in Gastric Cancer at AACR IO Annual Meeting

AGEN

Business Wire

9 months ago

CORRECTING and REPLACING Agenus’ BOT/BAL Selected for Two Presentations at Upcoming AACR IO Annual Meeting

AGEN

Zacks

9 months ago

Is Agenus (AGEN) Stock Outpacing Its Medical Peers This Year?

Travere Therapeutics (TVTX) Reports Q4 Loss, Tops Revenue Estimates

AGEN

Zacks

9 months ago

Travere Therapeutics (TVTX) Reports Q4 Loss, Tops Revenue Estimates

AGEN

Zacks

9 months ago

Agenus (AGEN) Is Attractively Priced Despite Fast-paced Momentum

AGEN

Zacks

9 months ago

Are Medical Stocks Lagging Agenus (AGEN) This Year?

AGEN

Business Wire

10 months ago

Agenus Announces Publication in the Journal of Clinical Oncology Highlighting Data from Botensilimab Plus Balstilimab in Relapsed/Refractory Metastatic Sarcomas

AGEN

Business Wire

10 months ago

Agenus Presents Data at ASCO GI Demonstrating Impact of BOT/BAL in Colorectal Cancer Across Neoadjuvant and Advanced Disease

AGEN

Zacks

10 months ago

What Makes Agenus (AGEN) a New Buy Stock

AGEN

Zacks

10 months ago

Is Agenus (AGEN) Stock Outpacing Its Medical Peers This Year?

AGEN

Business Wire

a year ago

Agenus Announces Five Presentations at ASCO GI Highlighting BOT/BAL Activity Across Colorectal and Gastric Cancers

AstraZeneca, Daiichi build cancer drug case; Amgen invests $1B

AGEN

BioPharma Dive

a year ago

AstraZeneca, Daiichi build cancer drug case; Amgen invests $1B

AGEN

Business Wire

a year ago

Agenus Announces Strategic Realignment to Focus on Core Programs and Significantly Reduce Costs

AGEN

Benzinga

a year ago

Agenus Gets $22M Mortgage, Plans Strategic Realignment To Focus On Colorectal Cancer Drug Development

AGEN

MT Newswires

a year ago

Agenus Secures $22 Million Mortgage, Plans Operational Realignment; Shares Jump

AGEN

Business Wire

a year ago

Agenus Secures $22 Million Mortgage and Announces Strategic Operational Realignment

AGEN

Zacks

a year ago

Agenus (AGEN) Loses -41.56% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

AGEN

Zacks

a year ago

Agenus (AGEN) Loses -41.13% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

AGEN

Zacks

a year ago

Down -39.39% in 4 Weeks, Here's Why Agenus (AGEN) Looks Ripe for a Turnaround

AGEN

Thomson Reuters StreetEvents

a year ago

Q3 2024 Agenus Inc Earnings Call

AGEN

GuruFocus.com

a year ago

Agenus Inc (AGEN) Q3 2024 Earnings Call Highlights: Navigating Financial Challenges While ...

AGEN

Motley Fool

a year ago

Agenus (AGEN) Q3 2024 Earnings Call Transcript

AGEN

Zacks

a year ago

Agenus (AGEN) Reports Q3 Loss, Lags Revenue Estimates

AGEN

Associated Press Finance

a year ago

Agenus: Q3 Earnings Snapshot

AGEN

Business Wire

a year ago

Agenus Reports Third Quarter 2024 Financial Results and Strategic Advancements in BOT/BAL Development

AGEN

GuruFocus.com

a year ago

Earnings To Watch: Agenus Inc (AGEN) Reports Q3 2024 Result

AGEN

Business Wire

a year ago

Agenus to Present Compelling Data on Botensilimab and AGEN1721 at SITC 2024

AGEN

Business Wire

a year ago

Agenus to Provide Third Quarter 2024 Financial Report and Corporate Update

AGEN

Business Wire

a year ago

Botensilimab/Balstilimab Clinical Responses in Refractory Sarcomas Presented at ESMO 2024

AGEN

MT Newswires

a year ago

Agenus Sued by Shareholder for Misleading Investors Over Colorectal Cancer Immuno-Therapy Trial Results

AGEN

Business Wire

a year ago

Botensilimab/Balstilimab Clinical Activity in Refractory Sarcomas to be Presented in Oral Session at ESMO 2024

AGEN

Business Wire

a year ago

Agenus to Participate in September Investor Conferences

AGEN

Motley Fool

a year ago

Agenus (AGEN) Q2 2024 Earnings Call Transcript

AGEN

Zacks

a year ago

Agenus (AGEN) Reports Q2 Loss, Lags Revenue Estimates

AGEN

Associated Press Finance

a year ago

Agenus: Q2 Earnings Snapshot

AGEN

Business Wire

a year ago

Agenus Announces Appointment of Tom Harrison to Board of Directors

AGEN

Business Wire

a year ago

Agenus Reports Second Quarter 2024 Operational and Financial Results

AGEN

Business Wire

a year ago

Agenus Publishes Seminal Study on Botensilimab’s Activity in Treatment-Resistant Cancers

AGEN

Benzinga

a year ago

Bristol Myers Squibb Terminates Cancer Drug Development Program With Agenus

AGEN

BioPharma Dive

a year ago

Bristol Myers sends TIGIT drug back to Agenus

AGEN

Zacks

a year ago

Agenus (AGEN) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release

AGEN

Zacks

a year ago

The Zacks Analyst Blog Highlights Sage Therapeutics, Biogen Agenus and BioMarin Pharmaceutical

AGEN

Business Wire

a year ago

Agenus to Provide Second Quarter 2024 Financial Report and Corporate Update

AGEN

Zacks

a year ago

Agenus (AGEN) Tanks on Colorectal Cancer Study Interim Data

Lilly alone in bidding for Morphic; Novartis won’t yet file MorphoSys drug

AGEN

BioPharma Dive

a year ago

Latest Agenus Inc. (AGEN) News on November 20, 2025

Share on Social Networks: